Computed tomography-derived sarcopenia, enteral nutritional support, and febrile neutropenia burden in children with acute lymphoblastic leukemia: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Computed tomography-derived sarcopenia, enteral nutritional support, and febrile neutropenia burden in children with acute lymphoblastic leukemia: a retrospective cohort study
Clinical Scorecard: Sarcopenia Assessed by Computed Tomography, Nutritional Support via Enteral Methods, and the Impact of Febrile Neutropenia in Pediatric Acute Lymphoblastic Leukemia: A Retrospective Cohort Analysis
At a Glance
Category
Detail
Condition
Acute Lymphoblastic Leukemia
Key Mechanisms
Sarcopenia and febrile neutropenia as complications of treatment
Target Population
Children aged 3–17 years with acute lymphoblastic leukemia
Care Setting
Pediatric oncology unit
Key Highlights
80% of patients with CT-derived data were sarcopenic.
Median febrile neutropenia episodes: 6.5.
Enteral nutritional support was associated with higher febrile neutropenia burden.
Sarcopenia was not significantly linked to febrile neutropenia or hospital stay.
Febrile neutropenia-related mortality observed in 17 patients.
Guideline-Based Recommendations
Diagnosis
Sarcopenia defined as total psoas muscle area z-score < −2.
Management
Consider enteral nutritional support as a marker of clinical severity.
Monitoring & Follow-up
Regular assessment of muscle mass and nutritional status in pediatric oncology patients.
Risks
Increased risk of febrile neutropenia and associated complications.
Patient & Prescribing Data
Children aged 3–17 years with acute lymphoblastic leukemia.
Enteral nutritional support may indicate clinical vulnerability rather than direct malnutrition.
Clinical Best Practices
Utilize CT for accurate assessment of muscle mass in pediatric patients.
Monitor nutritional status comprehensively, considering growth and developmental factors.
